Sabine Brookman‐May

4.1k total citations · 1 hit paper
125 papers, 1.7k citations indexed

About

Sabine Brookman‐May is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sabine Brookman‐May has authored 125 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 46 papers in Surgery and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sabine Brookman‐May's work include Prostate Cancer Treatment and Research (47 papers), Renal cell carcinoma treatment (31 papers) and Bladder and Urothelial Cancer Treatments (28 papers). Sabine Brookman‐May is often cited by papers focused on Prostate Cancer Treatment and Research (47 papers), Renal cell carcinoma treatment (31 papers) and Bladder and Urothelial Cancer Treatments (28 papers). Sabine Brookman‐May collaborates with scholars based in Germany, United States and United Kingdom. Sabine Brookman‐May's co-authors include Matthias May, Simon Chowdhury, Maximilian Burger, Suneel Mundle, Ke Zhang, Christian Gilfrich, Hans‐Martin Fritsche, Neeraj Agarwal, Hirotsugu Uemura and Axel S. Merseburger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sabine Brookman‐May

114 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

2021 285 citations Kim N., Simon Chowdhury et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Sabine Brookman‐May

Since Specialization

Citations

This map shows the geographic impact of Sabine Brookman‐May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Brookman‐May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Brookman‐May more than expected).

Fields of papers citing papers by Sabine Brookman‐May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Brookman‐May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Brookman‐May. The network helps show where Sabine Brookman‐May may publish in the future.

Co-authorship network of co-authors of Sabine Brookman‐May

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Brookman‐May. A scholar is included among the top collaborators of Sabine Brookman‐May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Brookman‐May. Sabine Brookman‐May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MOONRISE-1: PHASE 3 STUDY OF TAR-210, AN ERDAFITINIB INTRAVESICAL TARGETED RELEASING SYSTEM, VERSUS INTRAVESICAL CHEMOTHERAPY IN PATIENTS WITH FGFR-ALTERED INTERMEDIATE-RISK NON–MUSCLE-INVASIVE BLADDER CANCER 2025 ·Urologic Oncology Seminars and Original Investigations ·Roger Li, Gautam Jayram, Angela Girvin, Anne Marie O’Hagan, Sabine Brookman‐May, (unknown), Nicole L. Stone, (unknown), (unknown), (unknown), Neil Beeharry, Spyros Triantos, Benjamin Pradere	0
2	The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients—A Systematic Review and Meta-Analysis 2024 ·Cancers ·(unknown), Alexander Büchner, Stefan Brose, (unknown), Matthias May, Ingmar Wolff, (unknown), Christian G. Stief, Sabine Brookman‐May, (unknown)	0
3	Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer 2024 ·British Journal of Urology ·Pär Stattin, (unknown), Xiwu Lin, Florence Lefresne, Sabine Brookman‐May, Suneel Mundle, (unknown), Dina Gifkins, David Robinson, Johan Styrke, Hans Garmo	0
4	Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy 2024 ·British Journal of Urology ·Axel S. Merseburger, (unknown), Anders Bjartell, Hirotsugu Uemura, Álvaro Juárez Soto, Amitabha Bhaumik, Jürgen Böhm, Nguyen Toan Tran, (unknown), (unknown), Suneel Mundle, Sabine Brookman‐May, Angela Lopez‐Gitlitz, Sharon McCarthy, Kim Chi, Simon Chowdhury	8
5	Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study 2023 ·European Journal of Cancer ·Axel S. Merseburger, Neeraj Agarwal, Amitabha Bhaumik, Florence Lefresne, (unknown), Andrea Juliana Gomes, Álvaro Juárez Soto, Robert Given, Sabine Brookman‐May, Suneel Mundle, Sharon McCarthy, Hirotsugu Uemura, Simon Chowdhury, Kim N., Anders Bjartell	14
6	Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials 2023 ·European Urology Focus ·Matthias May, Christian Gilfrich, Johannes Bründl, Burkhard Ubrig, Joseph Wagner, (unknown), Vladimír Študent, Axel S. Merseburger, Christian Thomas, Sabine Brookman‐May, Ingmar Wolff	7
7	Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial 2023 ·Asian Journal of Andrology ·Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhangqun Ye, Hiroyoshi Suzuki, Taek Won Kang, Dalin He, Jae Young Joung, Sabine Brookman‐May, Sharon McCarthy, Amitabha Bhaumik, (unknown), Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Dingwei Ye, Kim N., Hirotsugu Uemura	3
8	A Rejected Hypothesis: Phenomenon of High Treatment Adherence in Direct-to-Consumer Teledermatology Despite Lack of Direct Physician–Patient Interaction 2022 ·Telemedicine Journal and e-Health ·(unknown), (unknown), (unknown), Sabine Brookman‐May, Kariem Sharaf, (unknown), Mattis Bertlich, Stefan W. Schneider, (unknown)	3
9	Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy 2021 ·European Urology Focus ·Stéphane Oudard, Boris Hadaschik, Fred Saad, David Cella, Ethan Basch, Julie N. Graff, Hiroji Uemura, Shiva Dibaj, Susan Li, Sabine Brookman‐May, Peter De Porre, Katherine B. Bevans, Jeremiah Trudeau, Eric J. Small, Matthew R. Smith	14
10	Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study breakdown → 2021 ·Journal of Clinical Oncology ·Kim N., Simon Chowdhury, Anders Bjartell, Byung Ha Chung, Andrea Juliana Gomes, Robert Given, Álvaro Juárez, Axel S. Merseburger, Mustafa Özgüroğlu, Hirotsugu Uemura, Dingwei Ye, Sabine Brookman‐May, Suneel Mundle, Sharon McCarthy, Julie S. Larsen, Weili Sun, Katherine B. Bevans, Ke Zhang, Nibedita Bandyopadhyay, Neeraj Agarwal	285
11	Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer 2021 ·JAMA Oncology ·Felix Y. Feng, Shibu Thomas, Fred Saad, Michael Gormley, Margaret K. Yu, Deborah Ricci, Brendan Rooney, Sabine Brookman‐May, Sharon McCarthy, David Olmos, Simon Chowdhury, Boris Hadaschik, Yang Liu, Elai Davicioni, Matthew R. Smith, Eric J. Small	21
12	Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis 2020 ·The Journal of Urology ·Petros Sountoulides, Nikolaos Pyrgidis, Sabine Brookman‐May, Ioannis Mykoniatis, Theofilos Karasavvidis, Dimitrios Hatzichristou	18
13	Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption—Results of a Survey in Urological Cancer Patients (KRAUT Study) 2018 ·Clinical Genitourinary Cancer ·(unknown), Matthias May, (unknown), (unknown), Hans‐Martin Fritsche, Sabine Brookman‐May, (unknown), Maximilian Burger, Christian Gilfrich	2
14	Wie werden der 10-Punkte-Plan des Deutschen Bundesministeriums für Gesundheit zur Bekämpfung resistenter Erreger und Maßnahmen des Antibiotic Stewardship wahrgenommen? Eine fachübergreifende Analyse der Kenntnis deutscher Klinikärzte und Entwicklung einer urologischen Handlungsanweisung 2017 ·(unknown), Malte W. Vetterlein, Florian Wagenlehner, Sabine Brookman‐May, Christian Gilfrich, Hans‐Martin Fritsche, (unknown), Marilise Escobar Bürger, Martin Schostak, Steffen Lebentrau	4
15	Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease 2017 ·PLoS ONE ·Nina Wagener, Dominic Edelmann, Axel Benner, Richard Zigeuner, Hendrik Borgmann, Ingmar Wolff, Laura Krabbe, Mireía Musquera, Paolo Dell’Oglio, Umberto Capitanio, Tobias Klatte, Luca Cindolo, Matthias May, Sabine Brookman‐May	25
16	p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models 2017 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Matthias May, Maximilian Burger, Wolfgang Otto, Georg C. Hutterer, Martin Pichler, Tobias Klatte, Peter J. Wild, Lorenz Buser, Sabine Brookman‐May	7
17	Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review 2017 ·World Journal of Urology ·Ó. Rodríguez Faba, Sabine Brookman‐May, Estefanía Linares, Alberto Breda, Francesca Pisano, José Daniel Subiela, Francesco Sanguedolce, Maurizio Brausi, Joan Palou	6
18	Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011 2016 ·World Journal of Urology ·Matthias May, Hans‐Martin Fritsche, Malte W. Vetterlein, Patrick J. Bastian, Michael Gierth, Philipp Nuhn, Atiqullah Aziz, Margit Fisch, Christian G. Stief, Markus Hohenfellner, Manfred P. Wirth, Vladimír Novotný, Oliver W. Hakenberg, Joachim Noldus, Christian Gilfrich, Christian Bolenz, Maximilian Burger, Sabine Brookman‐May	6
19	Current Status of Focal Cryoablation for Small Renal Masses 2015 ·Urology ·Ó. Rodríguez Faba, (unknown), Martin Marszalek, Johan F. Langenhuijsen, Sabine Brookman‐May, Grant D. Stewart, Umberto Capitanio, Francesco Sanguedolce	11
20	Das Ende eines Mythos: Die männliche Zirkumzision ist nicht mit einer höheren Prävalenz der erektilen Dysfunktion assoziiert – Ergebnisse der „Cottbuser 10.000-Männer-Fragebogenstudie“ 2014 ·Journal für Kardiologie (Krause & Pachernegg GmbH) ·Sabine Brookman‐May, B. Hoschke, (unknown), (unknown), Spivak Im, Christian Gilfrich, Ingmar Wolff, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact